The company had posted a net loss of Rs 424.92 crore for the corresponding period of 2017-18.
Sun Pharma had written to Sebi flagging concerns that certain entities were allegedly adopting unfair trade practices.
New Delhi: Sun Pharmaceutical Industries on Tuesday reported a consolidated net profit of Rs 982.51 crore for the quarter ended June 30, 2018.
The company had posted a net loss of Rs 424.92 crore for the corresponding period of 2017-18, Sun Pharma said in a filing to BSE. Consolidated total revenue from operations stood at Rs 7,224.17 crore for the reported quarter.
It was Rs 6,208.79 crore in the same period a year ago. The company's stock was trading at Rs 606.30 on BSE, up 7.74 per cent from the previous close.
( Source : PTI )
Next Story
